REQUEST A DEMO
Total
USD $0.00
Search more companies

Otsuka (Philippines) Pharmaceutical, Inc. (Philippines)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Otsuka (Philippines) Pharmaceutical, Inc. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Otsuka (Philippines) Pharmaceutical, Inc. is an enterprise in Philippines, with the main office in Makati. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Otsuka (Philippines) Pharmaceutical, Inc. was incorporated on December 17, 1997. The total number of employees is currently 50 (estimated).

Headquarters
3Rd Floor King's Court Ii Building
Makati; National Capital Region; Postal Code: 1231

Contact Details: Purchase the Otsuka (Philippines) Pharmaceutical, Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Otsuka (Philippines) Pharmaceutical, Inc. report to view the information.
Financial Auditors:
Purchase the Otsuka (Philippines) Pharmaceutical, Inc. report to view the information.
Incorporation Date:
December 17, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Otsuka (Philippines) Pharmaceutical, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Total Operating Revenue
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?